RecruitingNCT02282969

PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing

Promoting Informed Decisions About Lung Cancer Screening: Decision Aid Update and Measures Development


Sponsor

M.D. Anderson Cancer Center

Enrollment

620 participants

Start Date

Jul 11, 2014

Study Type

OBSERVATIONAL

Conditions

Summary

Objectives: This protocol addresses the first phase of a larger project funded by the Patient-Centered Outcomes Research Institute to help heavy smokers make informed decisions about lung cancer screening with low-dose computed tomography (CT). A separate IRB protocol will be submitted for the larger, comparative study. In this initial development phase, our prototype patient decision aid will be updated to reflect current guidelines about lung cancer screening. The updated aid will then be pilot-tested in a new sample of patients. In addition, several of the study measures will be refined and further developed in preparation for the larger study. The specific aims of the measures and decision aid development phase of this project are as follows: Update the aid to reflect current screening guidelines and refine the aid via cognitive testing with patients/smokers; and pilot test the updated aid for acceptability with patients/smokers. Modify our current measure of lung cancer knowledge, conduct cognitive testing of the new measure with patients/smokers, and evaluate the reliability of the new measure in a sample patients/smokers.


Eligibility

Min Age: 55 YearsMax Age: 80 Years

Inclusion Criteria3

  • Men and women 55 to 80 years of age.
  • Participants must speak English.
  • Current smoker or quit smoking within the past 15 years.

Exclusion Criteria1

  • \. History of lung cancer.

Interventions

BEHAVIORALInterviews

Interviews performed by study staff encompassing lung cancer screening and patient decision aids.

BEHAVIORALQuestionnaires

Questionnaires completed after viewing patient decision aid video. Questionnaires also completed regarding lung cancer screening knowledge at first visit, then again in one month.


Locations(2)

The University of Texas Medical Branch at Galveston

Galveston, Texas, United States

University of Texas MD Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02282969


Related Trials